
Sign up to save your podcasts
Or
Send us a text
Nick Jikomes talks to medicinal chemist Dr. David Olson whose lab at the University of California-Davis studies a class of compounds called ‘psychoplastogens,’ which are small molecules capable of promoting neural plasticity. His lab is on the cutting edge when it comes to understanding the mechanisms by which psychedelics and other psychoactive drugs work in the brain. They touch on: latest research from his lab, new tools they're developing and using to understand these drugs, whether it’s likely that we'll be able to produce non-hallucinogenic drug variants of classic psychedelics, and microdosing.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
4.8
7171 ratings
Send us a text
Nick Jikomes talks to medicinal chemist Dr. David Olson whose lab at the University of California-Davis studies a class of compounds called ‘psychoplastogens,’ which are small molecules capable of promoting neural plasticity. His lab is on the cutting edge when it comes to understanding the mechanisms by which psychedelics and other psychoactive drugs work in the brain. They touch on: latest research from his lab, new tools they're developing and using to understand these drugs, whether it’s likely that we'll be able to produce non-hallucinogenic drug variants of classic psychedelics, and microdosing.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
7,147 Listeners
5,301 Listeners
1,566 Listeners
654 Listeners
565 Listeners
419 Listeners
2,615 Listeners
7,916 Listeners
28,309 Listeners
187 Listeners
138 Listeners
459 Listeners
80 Listeners
64 Listeners
98 Listeners